Indian Journal of Pharmacology Home 

RESEARCH ARTICLE
[View FULLTEXT] [Download PDF]
Year : 2016  |  Volume : 48  |  Issue : 3  |  Page : 292--297

Weekly injection of histaglobulin produces long-term remission in chronic urticaria: A prospective clinical study

Gurumoorthy Rajesh1, Subramaniam Keerthi1, Kaliaperumal Karthikeyan1, Murugan Venkatesan2 
1 Department of Dermatology, Sri Manakula Vinayagar Medical College and Hospital, Puducherry, India
2 Department of Community Medicine, Sri Manakula Vinayagar Medical College and Hospital, Puducherry, India

Correspondence Address:
Dr. Gurumoorthy Rajesh
Department of Dermatology, Sri Manakula Vinayagar Medical College and Hospital, Puducherry
India

Objective: Treatment of chronic urticaria (CU) can be difficult in many patients. Achieving long-term remission and reducing the requirement of antihistamines are vital in CU. The objective of this study was to assess the effectiveness of injection histaglobulin, a complex of histamine and human immunoglobulin, in producing relief in patients with CU. Materials and Methods: Fifty-one patients with CU were enrolled into this prospective clinical study. Patients were administered 1 ml of injection histaglobulin subcutaneous for 8 consecutive weeks. They were also prescribed tablet levocetirizine 5 mg to be taken when required (but not more than the permitted dosage). Efficacy was assessed using urticaria activity score (UAS) which has a maximum score of 33/day, during each weekly visit. Final assessment was done after 24 weeks. Results: Twenty-nine patients had completed the entire 8-week drug regimen. Mean basal UAS was 18.9 ± 6.3 and it reduced to 80.4% by 8 weeks. The angioedema sub-score reduced by 89.8%. Anti-histamine pill burden also reduced significantly. By 24 weeks of starting the therapy, 23 patients (45%) had attained complete remission. No adverse effects to the drug were observed. Conclusions: Histaglobulin was found to be effective in producing long-term remission and it reduced the antihistamine requirement as well. Thus, it can serve as an effective alternative to existing treatment modalities.


How to cite this article:
Rajesh G, Keerthi S, Karthikeyan K, Venkatesan M. Weekly injection of histaglobulin produces long-term remission in chronic urticaria: A prospective clinical study.Indian J Pharmacol 2016;48:292-297


How to cite this URL:
Rajesh G, Keerthi S, Karthikeyan K, Venkatesan M. Weekly injection of histaglobulin produces long-term remission in chronic urticaria: A prospective clinical study. Indian J Pharmacol [serial online] 2016 [cited 2019 Nov 19 ];48:292-297
Available from: http://www.ijp-online.com/article.asp?issn=0253-7613;year=2016;volume=48;issue=3;spage=292;epage=297;aulast=Rajesh;type=0